PMC:7212965 / 43670-44328
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T101 | 179-194 | Body_part | denotes | digestive tract | http://purl.org/sig/ont/fma/fma317863 |
| T102 | 240-250 | Body_part | denotes | flatulence | http://purl.org/sig/ont/fma/fma78440 |
| T103 | 596-601 | Body_part | denotes | liver | http://purl.org/sig/ont/fma/fma7197 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T77 | 179-194 | Body_part | denotes | digestive tract | http://purl.obolibrary.org/obo/UBERON_0001555 |
| T78 | 596-601 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T226 | 48-56 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T227 | 525-533 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T228 | 565-573 | Disease | denotes | diarrhea | http://purl.obolibrary.org/obo/MONDO_0001673 |
| T229 | 602-608 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T330 | 79-84 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
| T331 | 179-194 | http://purl.obolibrary.org/obo/UBERON_0001555 | denotes | digestive tract |
| T332 | 268-271 | http://purl.obolibrary.org/obo/CLO_0001046 | denotes | 116 |
| T333 | 387-390 | http://purl.obolibrary.org/obo/CLO_0001046 | denotes | 116 |
| T334 | 415-420 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
| T335 | 588-590 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
| T336 | 596-601 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
| T337 | 596-601 | http://www.ebi.ac.uk/efo/EFO_0000887 | denotes | liver |
| T338 | 623-625 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T108 | 33-44 | Chemical | denotes | favipiravir | http://purl.obolibrary.org/obo/CHEBI_134722 |
| T109 | 79-84 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
| T110 | 93-104 | Chemical | denotes | favipiravir | http://purl.obolibrary.org/obo/CHEBI_134722 |
| T111 | 108-115 | Chemical | denotes | arbidol | http://purl.obolibrary.org/obo/CHEBI_134730 |
| T112 | 230-234 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
| T113 | 280-291 | Chemical | denotes | favipiravir | http://purl.obolibrary.org/obo/CHEBI_134722 |
| T114 | 292-297 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T115 | 348-351 | Chemical | denotes | AST | http://purl.obolibrary.org/obo/CHEBI_76649 |
| T116 | 415-420 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
| T117 | 438-449 | Chemical | denotes | favipiravir | http://purl.obolibrary.org/obo/CHEBI_134722 |
| T118 | 453-472 | Chemical | denotes | lopinavir/ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
| T119 | 453-462 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T120 | 463-472 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
| T121 | 504-514 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T201 | 216-222 | Phenotype | denotes | nausea | http://purl.obolibrary.org/obo/HP_0002018 |
| T202 | 565-573 | Phenotype | denotes | diarrhea | http://purl.obolibrary.org/obo/HP_0002014 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T293 | 0-57 | Sentence | denotes | There are 2 published studies on favipiravir in COVID-19. |
| T294 | 58-298 | Sentence | denotes | The first is an open-label RCT for favipiravir vs arbidol conducted in Wuhan, China by Chen et al.92 This study reported digestive tract reactions, including nausea, “anti-acid,” or flatulence in 13.79% (16 of 116) of the favipiravir group. |
| T295 | 299-392 | Sentence | denotes | Hepatotoxicity characterized by any elevation in AST or ALT was reported in 7.76% (9 of 116). |
| T296 | 393-658 | Sentence | denotes | The second is an open-label control study of favipiravir or lopinavir/ritonavir, both used in conjunction with interferon alfa, for COVID-19 by Cai et al,93 which reported diarrhea in 5.7% (2 of 35) and liver injury in 2.9% (1 of 35) (Supplementary Tables 2 and 3). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1205 | 33-44 | Chemical | denotes | favipiravir | MESH:C462182 |
| 1206 | 93-104 | Chemical | denotes | favipiravir | MESH:C462182 |
| 1207 | 108-115 | Chemical | denotes | arbidol | MESH:C086979 |
| 1208 | 280-291 | Chemical | denotes | favipiravir | MESH:C462182 |
| 1209 | 438-449 | Chemical | denotes | favipiravir | MESH:C462182 |
| 1210 | 453-472 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 1211 | 48-56 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1212 | 216-222 | Disease | denotes | nausea | MESH:D009325 |
| 1213 | 240-250 | Disease | denotes | flatulence | MESH:D005414 |
| 1214 | 299-313 | Disease | denotes | Hepatotoxicity | MESH:D056486 |
| 1215 | 525-533 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1216 | 565-573 | Disease | denotes | diarrhea | MESH:D003967 |
| 1217 | 596-608 | Disease | denotes | liver injury | MESH:D017093 |